The State of AI in Clinical Trials: Today and Tomorrow

Is your company keeping up with AI in clinical trials to drive real outcomes?

In a new survey of hundreds of clinical trial executives commissioned by Medidata¹, 93% said they are already using AI in their trials. Even more telling, nearly three-quarters report they’re realizing the value they expected. Organizations that embrace AI today are achieving transformative outcomes, while those that wait risk being left behind.

At Medidata, we believe the focus must shift from simply adopting AI to leveraging it for powerful, outcomes-based results. Our mission is to transform clinical development by using AI to drive successful trials. We invite you to explore this new path forward in our latest report and explore how AI is revolutionizing key aspects of clinical trials, including:

• Study Design & Planning: De-risk trials with advanced insights and simulations, optimizing protocols, and enhancing diversity.
• Study Start-Up and Execution: Improve feasibility assessments, live study forecasting, and protocol deviation management.
• Study Build: Start trials faster by rapidly accelerating study build and testing.
• Data Management: Turn complexity into clarity with cleaner, more reliable data.
• Patient and Site Data Acquisition: Gain near real-time insights for faster decision-making.
• Optimized Site Operations: Reduce burden and streamline contract negotiations, patient recruitment, and data collection.
• Patient Experience: Simplify participation with personalized engagement and frictionless data collection.

Don’t get left behind in this rapidly evolving environment. Download the report today to learn how to gain a competitive advantage by using AI to drive successful trials.

¹ Survey conducted by ISR Research